BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38800929)

  • 1. NSUN6 mediates 5-methylcytosine modification of METTL3 and promotes colon adenocarcinoma progression.
    Cui Y; Lv P; Zhang C
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23749. PubMed ID: 38800929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyltransferase like 3 enhances pinin mRNA stability through N
    He M; Jiang D; Xun A; Yang J; Luo Q; Wu H
    Exp Physiol; 2022 Nov; 107(11):1283-1297. PubMed ID: 35996844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation.
    Yang R; Liang X; Wang H; Guo M; Shen H; Shi Y; Liu Q; Sun Y; Yang L; Zhan M
    EBioMedicine; 2021 Jan; 63():103195. PubMed ID: 33418496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High miR-31-5p expression promotes colon adenocarcinoma progression by targeting TNS1.
    Mi B; Li Q; Li T; Liu G; Sai J
    Aging (Albany NY); 2020 Apr; 12(8):7480-7490. PubMed ID: 32315285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of the prognostic value of methylation regulators related to m5C in papillary thyroid carcinoma.
    Nie F; Jiang J; Ning J
    Medicine (Baltimore); 2024 Jun; 103(25):e38623. PubMed ID: 38905403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSUN6 Regulates NM23-H1 Expression in an m5C Manner to Affect Epithelial-Mesenchymal Transition in Lung Cancer.
    Lu Z; Liu B; Kong D; Zhou X; Pei D; Liu D
    Med Princ Pract; 2024; 33(1):56-65. PubMed ID: 38029727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cross-Tissue Investigation of Molecular Targets and Physiological Functions of Nsun6 Using Knockout Mice.
    Wang W; Huang H; Jiang H; Tian C; Tang Y; Gan D; Wen X; Song Z; He Y; Ou X; Fang L
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.
    Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J
    Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
    He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
    Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic effect of PNN in digestive tract cancers and its correlation with the tumor immune landscape in colon adenocarcinoma.
    Zhang H; Jin M; Ye M; Bei Y; Yang S; Liu K
    J Clin Lab Anal; 2022 Apr; 36(4):e24327. PubMed ID: 35257416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AEBP1, a prognostic indicator, promotes colon adenocarcinoma cell growth and metastasis through the NF-κB pathway.
    Xing Y; Zhang Z; Chi F; Zhou Y; Ren S; Zhao Z; Zhu Y; Piao D
    Mol Carcinog; 2019 Oct; 58(10):1795-1808. PubMed ID: 31219650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of high YY1AP1 and PCNA expression in colon adenocarcinoma.
    Ho YJ; Lin YM; Huang YC; Shi B; Yeh KT; Gong Z; Lu JW
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):173-180. PubMed ID: 29037809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the Prognostic Value and Clinical Significance of Interferon Regulatory Factors (IRFs) in Colon Adenocarcinoma.
    Yuemaier M; Zhou Z; Zhou Y; Wu C; Li F; Liang X; Kang H; Shen D; Gao F; Lin J
    Med Sci Monit; 2020 Nov; 26():e927073. PubMed ID: 33161410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLOD3 Is Associated with Immune Cell Infiltration and Genomic Instability in Colon Adenocarcinoma.
    Deng X; Pan Y; Yang M; Liu Y; Li J
    Biomed Res Int; 2021; 2021():4714526. PubMed ID: 34239923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m6A and m5C modification of GPX4 facilitates anticancer immunity via STING activation.
    Chen B; Hong Y; Zhai X; Deng Y; Hu H; Tian S; Zhang Y; Ren X; Zhao J; Jiang C
    Cell Death Dis; 2023 Dec; 14(12):809. PubMed ID: 38065948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer.
    Chen Y; Jiang Z; Zhang C; Zhang L; Chen H; Xiao N; Bai L; Liu H; Wan J
    J Biol Chem; 2024 Apr; 300(4):106793. PubMed ID: 38403250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
    Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
    Front Genet; 2022; 13():816173. PubMed ID: 35281843
    [No Abstract]   [Full Text] [Related]  

  • 18. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
    Jin L; Li C; Liu T; Wang L
    Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma.
    Li JB; Liu ZX; Zhang R; Ma SP; Lin T; Li YX; Yang SH; Zhang WC; Wang YP
    World J Gastroenterol; 2019 Jun; 25(22):2776-2787. PubMed ID: 31236000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSUN6 is a human RNA methyltransferase that catalyzes formation of m5C72 in specific tRNAs.
    Haag S; Warda AS; Kretschmer J; Günnigmann MA; Höbartner C; Bohnsack MT
    RNA; 2015 Sep; 21(9):1532-43. PubMed ID: 26160102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.